Claims for Adverse Reactions to Vaccine and Drugs under the Medicaid and Medically Needy Programs
Summary
HB 149 creates a new section of Florida Statutes directing the Agency for Health Care Administration (AHCA) to expedite review and payment of Medicaid and medically needy claims involving severe, debilitating, life-threatening, or lifelong injuries diagnosed by a physician as caused by a vaccine, immunizing agent, or an adverse reaction to an emergency countermeasure drug. The bill applies only when the vaccine, agent, or drug is recommended by the U.S. Food and Drug Administration or the Florida Department of Health.
The bill also requires AHCA to publish on its website lists of related medical conditions, potential adverse reactions identified in product inserts that are considered critical or disabling, newly identified conditions, and future vaccines or treatments deemed appropriate by the agency or diagnosing physicians. AHCA must also explain the section’s requirements online so providers can better serve patients with urgent needs, and it must seek federal approval if needed and adopt implementing rules. The act is titled “Cody’s Law: Florida No Vaccine-Injured Patient Left Behind” and takes effect July 1, 2025.
Impact
HB 149 would add a new statutory mandate to Florida’s Medicaid and medically needy programs by creating s. 409.9043, F.S., requiring expedited processing for certain injury-related claims tied to vaccines, immunizing agents, and emergency countermeasure drugs. It would also impose new website disclosure and administrative rulemaking duties on AHCA, and could require federal approval before implementation if Medicaid federal requirements are implicated. The bill affects Medicaid beneficiaries, medically needy enrollees, physicians, and AHCA claims administration procedures.
Sentiment
No committee transcripts or votes are available, so the bill’s sentiment must be inferred from its text and title. The measure appears strongly supportive of patients who allege serious vaccine- or drug-related injuries, framing the policy as a patient-protection and access-to-care measure. The title and structure suggest an intent to prioritize and validate claims from affected individuals rather than to limit them.
Contention
The main likely point of contention is the bill’s focus on vaccine-related injuries and whether state Medicaid should create a special expedited claims process for them. Supporters would likely emphasize faster access to care and payment for patients with severe injuries, while critics may question the medical and policy basis for singling out vaccine and emergency countermeasure claims, the administrative burden on AHCA, and whether the bill could conflict with federal Medicaid rules or broader public-health messaging. The requirement to publish lists of conditions and adverse reactions may also raise concerns about scope, accuracy, and potential implications for vaccine confidence.